Search - Université de Rennes Access content directly

Filter your results

14 Results
authFullName_s : Louis d'Alteroche

No evidence of hepatitis B virus reactivation among liver transplant recipients treated with interferon- free regimens for hepatitis C virus recurrence (ANRS CO23 CUPILT Cohort)

Lina Mouna , Emilie Rossignol , Mariagrazia Tateo , Jean-Charles Duclos-Vallee , Christophe Duvoux et al.
Hepatology, 2017, 66, pp.873A-874A
Journal articles hal-01769634v1

ABO blood group does not influence Child‐Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts

Isabelle Ollivier-Hourmand , Yohann Repesse , Pierre Nahon , Cendrine Chaffaut , Thông Dao et al.
Liver International, 2022, 42 (6), pp.1386-1400. ⟨10.1111/liv.15159⟩
Journal articles hal-03553907v1
Image document

Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study

Sébastien Dharancy , Audrey Coilly , Claire Fougerou-Leurent , Christophe Duvoux , Nassim Kamar et al.
American Journal of Transplantation, 2017, 17 (11), pp.2869-2878. ⟨10.1111/ajt.14490⟩
Journal articles hal-01640061v1
Image document

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment a prospective cohort study

Fabrice Carrat , Hélène Fontaine , Céline Dorival , Mélanie Simony , Alpha Diallo et al.
The Lancet, 2019, 393 (10179), pp.1453-1464. ⟨10.1016/S0140-6736(18)32111-1⟩
Journal articles hal-02050395v1

Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence Prophylaxis makes the difference

Lina Mouna , Emilie Rossignol , Mariagrazia Tateo , Audrey Coilly , Jean-Charles Duclos-Vallee et al.
Journal of Hepatology, 2019, 70 (6), pp.1297-1300. ⟨10.1016/j.jhep.2019.02.019⟩
Journal articles hal-02120675v1

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study

Audrey Coilly , Claire Fougerou-Leurent , Victor De Ledinghen , Pauline Houssel-Debry , Christophe Duvoux et al.
Journal of Hepatology, 2016, 65 (4), pp.711--718. ⟨10.1016/j.jhep.2016.05.039⟩
Journal articles hal-01395132v1

EFFICACY AND SAFETY OF TREATMENT WITH BULEVIRTIDE IN CHRONIC HEPATITIS DELTA: PRELIMINARY RESULTS OF THE REAL LIFE ANRS HD EP01 BULEDELTA COHORT

Fabien Zoulim , Claire Fougerou , Roulot Marullo Dominique , Sophie Metivier , Victor de Ledinghen et al.
Hepatology, 2022, 76 (Supp 1), pp.S221-S223
Journal articles hal-03922586v1

Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values results from the ANRS CO23 CUPILT cohort

Aurélie Barrail-Tran , Lauriane Goldwirt , Thibaut Gelé , Claire Laforest , Audrey Lavenu et al.
European Journal of Clinical Pharmacology, 2019, 75 (11), pp.1555-1563. ⟨10.1007/s00228-019-02725-x⟩
Journal articles hal-02280498v1

Efficacy of Sofosbuvir and Daclatasvir in Patients with Fibrosing Cholestatic Hepatitis C After Liver Transplantation

Vincent Leroy , Jérôme Dumortier , Audrey Coilly , Mylène Sebagh , Claire Fougerou-Leurent et al.
Clinical Gastroenterology and Hepatology, 2015, 13 (11), pp.1993-2001.e2. ⟨10.1016/j.cgh.2015.05.030⟩
Journal articles hal-01162384v1

Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.

Paul Calès , Philippe Halfon , Dominique Batisse , Fabrice Carrat , Philippe Perré et al.
Journal of Hepatology, 2010, 53 (2), pp.238-44. ⟨10.1016/j.jhep.2010.03.007⟩
Journal articles istex hal-00665946v1

Daclatasvir plus sofosbuvir with or without ribavirin in genotype 3 patients from a large French multicenter compassionate use program

Christophe Hézode , Victor De Ledinghen , Hélène Fontaine , Fabien Zoulim , Pascal Lebray et al.
Hepatology, 2015, 62, pp.314A--314A. ⟨10.1002/hep.28160⟩
Journal articles hal-01380169v1
Image document

Personalized surveillance for hepatocellular carcinoma in cirrhosis – using machine learning adapted to HCV status

Etienne Audureau , Fabrice Carrat , Richard Layese , Carole Cagnot , Tarik Asselah et al.
Journal of Hepatology, 2020, 73 (6), pp.1434-1445. ⟨10.1016/j.jhep.2020.05.052⟩
Journal articles hal-03284519v1

Sofosbuvir and NS5A inhibitors without Ribavirin during 12 weeks are efficient to treat hepatitis C recurrence after liver transplantation only in genotype 1. Results from the CO23 ANRS CUPILT study.

Pauline Houssel-Debry , Audrey Coilly , Claire Fougerou-Leurent , Caroline Jezequel , Christophe Duvoux et al.
Hepatology, 2017, 63 (1 SUPP), pp.465A--465A
Journal articles hal-01412958v1

12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation

Pauline Houssel-Debry , Audrey Coilly , Claire Fougerou-Leurent , Caroline Jezequel , Christophe Duvoux et al.
Hepatology, 2018, 68 (4), pp.1277-1287. ⟨10.1002/hep.29918⟩
Journal articles hal-01807755v1